Pilpel et al. have reported that a mouse model of Fragile X syndrome (Fmr1 KO2) displays a significantly lower AMPA to NMDA ratio than WTs at 2 weeks of post-natal development but not at 6–7 weeks of age53. This evidence concerns the gene FMR1 and fragile X syndrome.